Valuation: Clover Corporation Limited

Market Cap 171M 119M 106M 98.59M 89.86M 169M 11.43B 1.19B 462M 5.84B 446M 437M 18.75B P/E 2027 *
12.6x
P/E 2028 * 10.1x
Enterprise Value 157M 109M 96.74M 90.29M 82.3M 155M 10.47B 1.09B 423M 5.35B 409M 400M 17.17B EV / Sales 2027 *
1.36x
EV / Sales 2028 * 1.11x
Free-Float
76.93%
Yield 2027 *
2.18%
Yield 2028 * 2.18%
1 day-1.44%
1 week+5.10%
Current month-1.44%
1 month+18.39%
3 months+25.61%
6 months-2.83%
Current year+30.38%
1 week 0.99
Extreme 0.99
1.11
1 month 0.84
Extreme 0.84
1.11
Current year 0.7
Extreme 0.7
1.16
1 year 0.62
Extreme 0.615
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/18/25 A Sell

Chief Executive Officer

255,199 0.1528%
11/18/25 A Buy

Chief Executive Officer

529,638 0.3171%
11/6/25 A Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%+5.10%+46.10%-1.90% 120M
+0.20%-4.05%+1.22%-27.92% 231B
+0.74%-3.42%-5.81%-15.04% 73.72B
+2.67%-1.70%-19.50%+13.13% 41.7B
+1.17%-0.83%+36.10%+8.42% 38.33B
+0.56%-3.71%-15.25%-19.51% 32.01B
-0.91%+4.28%+22.78%+80.85% 31.88B
+0.79%-2.24%-14.86%-12.69% 28.39B
-1.20%-6.09%-14.88%-32.94% 26.63B
-0.62%-3.65%+11.80%+15.93% 26.11B
Average +0.26%-2.43%+4.77%+0.83% 53B
Weighted average by Cap. +0.45%-3.86%+0.30%-10.49%

Financials

2027 *2028 *
Net sales 115M 79.89M 70.98M 66.25M 60.39M 114M 7.68B 802M 311M 3.93B 300M 293M 12.6B 132M 91.67M 81.45M 76.02M 69.29M 131M 8.81B 920M 357M 4.51B 344M 337M 14.46B
Net income 13.7M 9.52M 8.46M 7.9M 7.2M 13.57M 915M 95.56M 37.03M 468M 35.75M 34.97M 1.5B 17M 11.82M 10.5M 9.8M 8.93M 16.84M 1.14B 119M 45.95M 581M 44.36M 43.4M 1.86B
Net Debt -14.4M -10.01M -8.89M -8.3M -7.56M -14.27M -962M -100M -38.92M -492M -37.58M -36.76M -1.58B -24.9M -17.31M -15.38M -14.35M -13.08M -24.67M -1.66B -174M -67.3M -850M -64.98M -63.57M -2.73B
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
81
Date Price Change Volume
02/10/26 A$1.030 -1.44% 65,121
01/10/26 A$1.045 0.00% 1,070,949
30/09/26 A$1.045 +3.98% 231,304
29/09/26 A$1.005 +0.50% 25,867
28/09/26 A$1.000 -7.41% 228,372
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.030AUD
Average target price
1.315AUD
Spread / Average Target
+27.67%

Annual profits - Rate of surprise